Biote Net Income From Continuing Ops from 2010 to 2026
| BTMD Stock | USD 2.13 0.04 1.91% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 41.4 K | Current Value 39.3 K | Quarterly Volatility 11.3 M |
Check Biote Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biote Corp's main balance sheet or income statement drivers, such as Tax Provision of 1.4 M, Depreciation And Amortization of 4.3 M or Interest Expense of 13.3 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0245 or Days Sales Outstanding of 11.67. Biote financial statements analysis is a perfect complement when working with Biote Corp Valuation or Volatility modules.
Biote | Net Income From Continuing Ops | Build AI portfolio with Biote Stock |
Analyzing Biote Corp's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Biote Corp's current valuation and future prospects.
Latest Biote Corp's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of biote Corp over the last few years. It is Biote Corp's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biote Corp's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Biote Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 16,119,278 | |
| Coefficient Of Variation | 69.96 | |
| Mean Deviation | 9,555,254 | |
| Median | 21,287,000 | |
| Standard Deviation | 11,276,956 | |
| Sample Variance | 127.2T | |
| Range | 34.7M | |
| R-Value | (0.65) | |
| Mean Square Error | 78.2T | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | (1,453,572) | |
| Total Sum of Squares | 2034.7T |
Biote Net Income From Continuing Ops History
About Biote Corp Financial Statements
Biote Corp stakeholders use historical fundamental indicators, such as Biote Corp's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Biote Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biote Corp's assets and liabilities are reflected in the revenues and expenses on Biote Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in biote Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 41.4 K | 39.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:Check out the analysis of Biote Corp Correlation against competitors. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Will Health Care Equipment & Supplies sector continue expanding? Could Biote diversify its offerings? Factors like these will boost the valuation of Biote Corp. Projected growth potential of Biote fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biote Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.33) | Earnings Share 0.78 | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
biote Corp's market price often diverges from its book value, the accounting figure shown on Biote's balance sheet. Smart investors calculate Biote Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Biote Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Biote Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biote Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.